Who
Alvin Shih
Director
Company insider
Files Form 4 as: Director, Zevra Therapeutics; EVP of Research & Development, Travere Therapeutics.
In numbers
- Trades disclosed
- 16
- Buys
- 1
- Sells
- 6
- Bought
- $158K
- Sold
- $1.7M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 26 Jun 2015
- Last trade
- 4 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 18 Jun 2026 | ZVRA Zevra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 4 Jun 2026filed 18 Jun 2026 | ZVRA Zevra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 12 Sep 2025filed 15 Sep 2025 | ZVRA Zevra TherapeuticsBiotechnology | SEC FORM 4 Bought | $158K20,000 at $7.89 | filing |
| 29 May 2025filed 30 May 2025 | ZVRA Zevra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 13 May 2024filed 15 May 2024 | ZVRA Zevra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,200 at $0.00 | filing |
| 20 Jan 2024filed 2 Feb 2024 | ZVRA Zevra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —58,800 at $0.00 | filing |
| 1 Sep 2016filed 2 Sep 2016 | TVTX Travere TherapeuticsBiotechnology | SEC FORM 4 Sold | $142K8,750 at $16.24 | filing |
| 1 Jun 2016filed 2 Jun 2016 | TVTX Travere TherapeuticsBiotechnology | SEC FORM 4 Sold | $155K8,750 at $17.75 | filing |
| 19 May 2016filed 23 May 2016 | TVTX Travere Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 1 Mar 2016filed 1 Mar 2016 | TVTX Travere TherapeuticsBiotechnology | SEC FORM 4 Sold | $126K8,750 at $14.35 | filing |
| 9 Dec 2015filed 10 Dec 2015 | TVTX Travere TherapeuticsBiotechnology | SEC FORM 4 Sold | $182K8,750 at $20.83 | filing |
| 6 Oct 2015filed 8 Oct 2015 | TVTX Travere TherapeuticsBiotechnology | SEC FORM 4 Sold | $94K4,798 at $19.58 | filing |
| 6 Oct 2015filed 8 Oct 2015 | TVTX Travere TherapeuticsBiotechnology | SEC FORM 4 Sold | $58K2,823 at $20.45 | filing |
| 6 Oct 2015filed 8 Oct 2015 | TVTX Travere TherapeuticsBiotechnology | SEC FORM 4 Sold | $24K1,129 at $21.61 | filing |
| 1 Jul 2015filed 2 Jul 2015 | TVTX Travere Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 26 Jun 2015filed 30 Jun 2015 | TVTX Travere TherapeuticsBiotechnology | SEC FORM 4 Sold | $913K27,916 at $32.70 | filing |
News
No headline names them, or the companies they trade most, lately.